Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal TXA for Anterior Epistaxis
NCT04054687Phase 2Suspended
- Sponsor
- Mercy
- Start
- Nov 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid in epistaxis, sponsored by Mercy. Started Nov 2019; status: suspended.
02
Drugs
tranexamic acid
03
Conditions
epistaxis
Beyond the preview
Go deeper on NCT04054687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04054687.